• Kraychete Durval Campos DC Ambulatório de Dor, UFBA., Ana Cristina Guimarães, Maria Goreth Carvalho, and Edgar Marcelino de Carvalho.
• Ambulatório de Dor, UFBA.
• Rev Bras Anestesiol. 2003 Dec 1; 53 (6): 797-801.

Background And ObjectivesScleroderma or progressive systemic sclerosis is a systemic connective tissue disease of unknown origin, which normally courses with microangiopathy, extremities ischemia and severe pain. This report aimed at describing a case of intravenous lidocaine to treat ischemic pain and at emphasizing potential anti-inflammatory action of local anesthetics in scleroderma patients.Case ReportFemale patient, clear mulatto 34 years old, nursing assistant, with scleroderma for approximately 8 years, presented with severe continuous, daily pain (numeric scale = 10) in upper and lower limbs, followed by trophic, color and temperature changes, and small ulcers on extremities. Patient was submitted to 1 weekly session of intravenous 2% lidocaine (400 mg) without vasoconstrictor for 10 weeks with pain, turgor, skin elasticity and peripheral perfusion improvement.ConclusionsPain and other symptoms relief after intravenous lidocaine suggests that local anesthetics are able to modulate inflammatory response in different scleroderma stages.

4 keywords...

hide…